Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 -3.544M
March 31, 2026 -2.892M
December 31, 2025 -2.969M
September 30, 2025 -3.753M
June 30, 2025 -2.668M
March 31, 2025 -2.509M
December 31, 2024 -2.301M
Date Value
September 30, 2024 -1.596M
June 30, 2024 -1.852M
March 31, 2024 -2.287M
December 31, 2023 -2.557M
September 30, 2023 -1.143M
June 30, 2023 -0.661M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 2.488B
AngioDynamics, Inc. -15.33M
Alphatec Holdings, Inc. 20.51M
AtriCure, Inc. 22.19M
Baxter International, Inc. 285.00M

Cash from Operations (Quarterly) Related Metrics